AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 19157318
Drug: Methadone +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methadone + TENS (10-30 mg daily, tapered over 2 weeks with TENS treatment)
Trial: 7930339
Drug: Methylprednisolone (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone (10 mg intravenous dose)
Trial: 3168338
Drug: Ionic amidotrizoate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ionic amidotrizoate (370 mg/ml, osmolality 2.1 osmol/kg)
Trial: 3168338
Drug: Nonionic iopamidol
RxNorm normalized name: Iopamidol
DrugBank: Iopamidol (DB08947)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nonionic iopamidol (370 mg/ml, osmolality 0.8 osmol/kg)
Trial: 20002085
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg voriconazole orally
Trial: 20002085
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg voriconazole intravenously
Trial: 11707792
Drug: Intradermal needles
RxNorm normalized name: NEEDLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradermal needles inserted into painful points
Trial: 11707792
Drug: Sham treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham treatment (needles inserted into nonpainful points)
Trial: 15374366
Drug: Idebenone (CV-2619)
DrugBank: Idebenone (DB09081)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Idebenone (CV-2619) 90 mg/daily
Trial: 6376128
Drug: High-dose cis-platinum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose cis-platinum (100 mg/m2) + adriamycin (60 mg/m2)
Trial: 6376128
Drug: Adriamycin (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adriamycin (60 mg/m2) + cis-platinum (60 mg/m2)
Trial: 26401858
Drug: Local levobupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local levobupivacaine infiltration (20 mL of levobupivacaine 0.25%)
Trial: 26401858
Drug: Intravenous paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous paracetamol (1g before extubation and 5g in the 24 postoperative period)
Trial: 26401858
Drug: Intravenous lornoxicam
RxNorm normalized name: lornoxicam
DrugBank: Lornoxicam (DB06725)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous lornoxicam (8 mg before extubation and 8 mg in the 24 postoperative period)
Trial: 17404779
Drug: Melatonin (3mg)
RxNorm normalized name: melatonin 3 MG
DrugBank: Melatonin (DB01065)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Melatonin (3mg) administered one hour before bedtime for four weeks
Trial: 17404779
Drug: Placebo administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administered one hour before bedtime for four weeks
Trial: 11498721
Drug: Oral cocaine
RxNorm normalized name: Cocaine
DrugBank: Cocaine (DB00907)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral cocaine (62.5, 125, 250 mg/70 kg)
Trial: 11498721
Drug: Intravenous cocaine
RxNorm normalized name: Cocaine
DrugBank: Cocaine (DB00907)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous cocaine (12.5, 25, 50 mg/70 kg)
Trial: 11498721
Drug: Oral cocaine
RxNorm normalized name: Cocaine
DrugBank: Cocaine (DB00907)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral cocaine
Trial: 11498721
Drug: Intravenous cocaine
RxNorm normalized name: Cocaine
DrugBank: Cocaine (DB00907)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous cocaine
Trial: 11498721
Drug: Both oral
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both oral and intravenous cocaine
Trial: 9919334
Drug: CPT-11 (irinotecan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CPT-11 (irinotecan hydrochloride) at a dose of 120 mg/m2 i.v. over 4 hours on days 1 and 15, and mitomycin-C (MMC) at a dose of 7 mg/m2 i.v. as a bolus on days 1 and 15, given for at least 2 cycles, 4 weeks apart.
Trial: 9114186
Drug: Oral azithromycin
RxNorm normalized name: Azithromycin
DrugBank: Azithromycin (DB00207)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral azithromycin (20 mg/kg) administered as a single dose, one dose a week for 3 weeks, or one dose every 4 weeks for a total of six doses
Trial: 9114186
Drug: Topical oxytetracycline/polymyxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical oxytetracycline/polymyxin eye ointment (once daily for 5 days every 4 weeks; total of six treatment cycles)
Trial: 2667325
Drug: High-dose methotrexate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose methotrexate pretreatment at 0 h before 5-FU
Trial: 2667325
Drug: High-dose methotrexate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose methotrexate pretreatment at 3 h before 5-FU
Trial: 2667325
Drug: High-dose methotrexate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose methotrexate followed by 5-FU (both doses: 1,000 mg/m2)
Trial: 8814
Drug: Chlorpromazine (CPZ)
RxNorm normalized name: Chlorpromazine
DrugBank: Chlorpromazine (DB00477)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chlorpromazine (CPZ) treatment after placebo
Trial: 8814
Drug: Acute CPZ
RxNorm normalized name: CPZ
DrugBank: Chlorpromazine (DB00477)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acute CPZ treatment
Trial: 27657350
Drug: Magnetic field
RxNorm normalized name: Field mushroom
DrugBank: Field mushroom (DB15605)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnetic field therapy (MFT)
Trial: 21975668
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (GH) 0.14 mg/kg/d for 4 months
Trial: 21975668
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (CTR) after GH treatment
Trial: 21975668
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (GH) after discontinuation
Trial: 11301406
Drug: Oral ciprofloxacin
RxNorm normalized name: Ciprofloxacin
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ciprofloxacin 20 mg/kg/day p.o. every 12 hours for 6 days
Trial: 11301406
Drug: Intravenous ceftriaxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ceftriaxone plus amikacin for 2 days more followed by cefixime 8 mg/kg/day p.o. every 24 hours for 4 additional days
Trial: 8275912
Drug: Paroxetine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine (20 mg o.d.)
Trial: 8275912
Drug: Clomipramine (increasing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clomipramine (increasing from 20 mg o.d. to 20 mg tds)
Trial: 30563538
Drug: βA (2.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: βA (2.4 g·d-1, βA1)
Trial: 30563538
Drug: Matched total
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Matched total βA (4.8 g on alternate days, βA2)
Trial: 30563538
Drug: Cornflour placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cornflour placebo (2.4 g·d-1, PL)
Trial: 28247635
Drug: Basic therapy
RxNorm normalized name: Basic Fuchsin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basic therapy combined with 10 treatment sessions of hypercapnic hypoxia using a respiratory device
Trial: 12435256
Drug: Hormone Replacement
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone Replacement Therapy (HRT) - 0.625 mg/d of conjugated equine estrogen (plus 2.5 mg/d of medroxyprogesterone acetate for women who had not had a hysterectomy)
Trial: 12435256
Drug: Antioxidant vitamins
RxNorm normalized name: antioxidant vitamins with minerals
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidant vitamins - 400 IU of vitamin E twice daily plus 500 mg of vitamin C twice daily
Trial: 30945297
Drug: Pomegranate seed
RxNorm normalized name: pomegranate seed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pomegranate seed oil (PSO) - 1 g daily for 8 weeks
Trial: 21544980
Drug: Filgrastim (G-CSF)
RxNorm normalized name: Filgrastim
DrugBank: Filgrastim (DB00099)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Filgrastim (G-CSF) administration
Trial: 17446439
Drug: N(G)-monomethyl-L-arginine (nitric
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N(G)-monomethyl-L-arginine (nitric oxide synthase inhibitor)
Trial: 15121945
Drug: Zinc supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc supplementation (5 mg of zinc sulfate daily)
Trial: 12516191
Drug: Benzylpenicillin (1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benzylpenicillin (1.0 g four times daily, i/v) combined with ciprofloxacin (0.5 g twice daily, per os)
Trial: 12516191
Drug: Ciprofloxacin (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin (0.5 g twice daily, per os)
Trial: 9695301
Drug: Benzathine penicillin
RxNorm normalized name: Benzathine penicillin G
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benzathine penicillin G (BPG) prophylaxis every 3 weeks as a single intramuscular injection of 1.2 million units for children over 27 kg, and a half dose for those 27 kg or less.
Trial: 7857351
Drug: Pidotimod 800
RxNorm normalized name: pidotimod
DrugBank: Pidotimod (DB11364)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pidotimod 800 mg/die for 60 days
Trial: 2751741
Drug: Antacid (Trigastril)
DrugBank: Dimethicone (DB11074)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Antacid (Trigastril) with 50 mg pirenzepine
Trial: 2751741
Drug: Placebo gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo gel with 50 mg pirenzepine
Trial: 797592
Drug: Betamethasone dipropionate
RxNorm normalized name: Betamethasone Dipropionate
DrugBank: Betamethasone (DB00443)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Betamethasone dipropionate cream (Diprosone)
Trial: 797592
Drug: Locacorten 0.02%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Locacorten 0.02% cream
Trial: 31478335
Drug: Gemigliptin 50
RxNorm normalized name: gemigliptin
DrugBank: Gemigliptin (DB12412)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemigliptin 50 mg once daily
Trial: 25178520
Drug: Long-term group
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term group psychotherapy (LTG) - 80 weekly sessions of 90 min each
Trial: 25178520
Drug: Short-term group
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Short-term group psychotherapy (STG) - 20 weekly sessions of 90 min each
Trial: 21453230
Drug: Steroid-free regimen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid-free regimen (tacrolimus, mycophenolate mofetil, steroids for only 3 days)
Trial: 21453230
Drug: Steroid-maintenance regimen
RxNorm normalized name: Anacin Aspirin Regimen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid-maintenance regimen (tacrolimus, mycophenolate mofetil, steroids on a maintenance basis)
Trial: 18079005
Drug: Peritonsillar injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peritonsillar injection of tramadol (2 mg/kg)
Trial: 18079005
Drug: Intramuscular analgesia
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular analgesia with tramadol (2 mg/kg)
Trial: 12829675
Drug: Temozolomide 200
RxNorm normalized name: Temozolomide
DrugBank: Temozolomide (DB00853)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Temozolomide 200 mg/m2 every 8 hours for five doses
Trial: 12829675
Drug: Temozolomide 200
RxNorm normalized name: Temozolomide
DrugBank: Temozolomide (DB00853)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Temozolomide 200 mg/m2 daily for days 1 to 5 plus interferon alfa‐2b 5 MU subcutaneously three times a week
Trial: 12829675
Drug: Temozolomide 150
RxNorm normalized name: Temozolomide
DrugBank: Temozolomide (DB00853)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Temozolomide 150 mg/m2 (increased after one cycle to 200 mg/m2) daily on days 1 to 5 plus thalidomide 100 mg daily days 1 to 28
Trial: 1466441
Drug: Hudson mask
RxNorm normalized name: MASK,TRACHEOSTOMY HUDSON #1075
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hudson mask (48 l.min‐1)
Trial: 1466441
Drug: Magill system
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magill system (100 ml.kg‐1.min‐1)
Trial: 6689974
Drug: low-dose heparin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: low-dose heparin combined with dihydroergotamine (HDHE)
Trial: 14636900
Drug: Low-dose dobutamine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose dobutamine echocardiography (up to 10 microg/kg/min)
Trial: 9056614
Drug: Perindopril (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril (4 mg for 15 days)
Trial: 8365524
Drug: Vaginal progesterone
RxNorm normalized name: progesterone Vaginal Insert
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal progesterone (25 mg b.i.d.) during cycle days 16-24 for 10 months
Trial: 8365524
Drug: Vaginal progesterone
RxNorm normalized name: progesterone Vaginal Insert
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal progesterone (25 mg b.i.d.)
Trial: 3805300
Drug: Stress inoculation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stress inoculation therapy
Trial: 3805300
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of stress inoculation and medication therapy
Trial: 26578361
Drug: Continuous ultrasound
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous ultrasound therapy (0.4 W/cm(2 SATA))
Trial: 26578361
Drug: Pulsed ultrasound
RxNorm normalized name: ULTRASOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsed ultrasound therapy (20% duty cycle, 0.08 W/cm(2 SATA))
Trial: 26578361
Drug: Continuous ultrasound
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous ultrasound therapy (0.4 W/cm(2 SATA)) after COX inhibition (aspirin)
Trial: 26578361
Drug: Pulsed ultrasound
RxNorm normalized name: ULTRASOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsed ultrasound therapy (20% duty cycle, 0.08 W/cm(2 SATA)) after COX inhibition (aspirin)
Trial: 20590434
Drug: 6-session psychoeducative
RxNorm normalized name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 60 mg in 1 mL TOPICAL LOTION [SESSION SAVERS SUNSCREEN BROAD SPECTRUM SPF 30 WATER RESISTANT]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6-session psychoeducative group therapy module
Trial: 19013336
Drug: Liposomal amphotericin
RxNorm normalized name: Liposomal amphotericin B
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Liposomal amphotericin B (L‐AmB) 3 mg/kg/day
Trial: 19013336
Drug: Liposomal amphotericin
RxNorm normalized name: Liposomal amphotericin B
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Liposomal amphotericin B (L‐AmB) 10 mg/kg/day
Trial: 15804471
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg of aspirin once a day for 14 days
Trial: 15804471
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg of aspirin once a day for 14 days
Trial: 15804471
Drug: Placebo tablet
RxNorm normalized name: placebo Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo tablet for 14 days
Trial: 15804471
Drug: All groups
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All groups (75 mg, 300 mg, and placebo)
Trial: 15804471
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg and 300 mg of aspirin
Trial: 1518264
Drug: Continuous epinephrine
RxNorm normalized name: Epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuous epinephrine infusion (0.01-0.02 mg/kg) started one hour before and finished one hour after the infusion of E. coli L-asparaginase
Trial: 30296472
Drug: Eating As
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eating As Treatment (EAT) intervention delivered by oncology dietitians
Trial: 30296472
Drug: Eating As
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eating As Treatment (EAT) intervention
Trial: 30307410
Drug: Tacrolimus plus
RxNorm normalized name: Tacrolimus
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tacrolimus plus a single, intraoperative, high-dose (9 mg/kg) rabbit anti-T-lymphocyte globulins (ATLG)
Trial: 30307410
Drug: Tacrolimus monotherapy
RxNorm normalized name: Tacrolimus
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tacrolimus monotherapy (TAC)
Trial: 26977624
Drug: Remaxol (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remaxol (400 ml intravenously, 2 times a day for 7 days)
Trial: 26977624
Drug: Saline with
RxNorm normalized name: CVS Saline with Aloe Nasal Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline with 25%-magnesium sulfate (10 ml) and 4% potassium chloride (10 ml)
Trial: 20825615
Drug: 20 mL/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mL/kg perfluorocarbon
Trial: 20825615
Drug: 30 mL/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mL/kg perfluorocarbon
Trial: 20825615
Drug: 40 mL/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mL/kg perfluorocarbon
Trial: 17879531
Drug: Migu Tablet
RxNorm normalized name: Pseudomonas aeruginosa (schroeter, 1872) migula, 1900
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Migu Tablet group (MGTG)
Trial: 12376205
Drug: Weekly cisplatin
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Weekly cisplatin 70 mg/m² (days 1, 8, 15, 29, 36, 43) in combination with escalating doses of paclitaxel (225 mg/m² 4-weekly or 100 mg/m² weekly)
Trial: 10102059
Drug: 0.1 IU/kg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 IU/kg/day (0.03 mg/kg/day), administered once daily (Group A)
Trial: 10102059
Drug: 0.2 IU/kg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 IU/kg/day (0.07 mg/kg/day), administered once daily (Group B)
Trial: 10102059
Drug: 0.2 IU/kg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 IU/kg/day (0.07 mg/kg/day), divided into two equal injections given at 12‐hour intervals (Group C)
Trial: 2221415
Drug: 10% Intralipid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% Intralipid (3 mL/min for 20 min)
Trial: 2221415
Drug: 5% dextrose
RxNorm normalized name: LMD with 5% Dextrose
DrugBank: D-glucose (DB01914)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% dextrose in lactated Ringer's solution
Trial: 348222
Drug: Fentanyl 0.1
RxNorm normalized name: fentanyl 0.1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 0.1 mg and Morphine 10 mg with Droperidol 2.5 mg
Trial: 348222
Drug: Fentanyl 0.1
RxNorm normalized name: fentanyl 0.1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 0.1 mg and Morphine 10 mg with Droperidol 5.0 mg
Trial: 348222
Drug: Fentanyl 0.1
RxNorm normalized name: fentanyl 0.1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 0.1 mg and Morphine 10 mg (without Droperidol)
Trial: 26016870
Drug: MFGM diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MFGM diet (whipping cream, 40 g milk fat/d)
Trial: 26016870
Drug: Control diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control diet (butter oil, 40 g milk fat/d)
Trial: 20594878
Drug: Lidocaine (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine (3 mg/kg/h) and Ketamine (0.6 mg/kg/h) with Morphine (0.24 mg/kg/h)
Trial: 20594878
Drug: Lidocaine (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine (3 mg/kg/h) and Ketamine (0.6 mg/kg/h) with Fentanyl (0.0036 mg/kg/h)
Trial: 20594878
Drug: Ringer's lactate
RxNorm normalized name: Ringer's lactate/gel dressing 2.2" TOPICAL KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ringer's lactate solution (Control)
Trial: 19621198
Drug: Ornithine alpha-ketoglutarate
RxNorm normalized name: ornithine alpha-ketoglutarate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ornithine alpha-ketoglutarate (OKG) 10g daily
Trial: 17293085
Drug: Mecamylamine (MEC)
DrugBank: Mecamylamine (DB00657)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mecamylamine (MEC) 0.0 mg/day
Trial: 17293085
Drug: Mecamylamine (MEC)
DrugBank: Mecamylamine (DB00657)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mecamylamine (MEC) 5.0 mg/day
Trial: 17293085
Drug: Mecamylamine (MEC)
DrugBank: Mecamylamine (DB00657)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mecamylamine (MEC) 10.0 mg/day
Trial: 10364862
Drug: Conventional Insyte
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional Insyte intravenous cannula (group C)
Trial: 8759372
Drug: Soy protein
RxNorm normalized name: Soy Protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy protein isolate beverage powder (60 g/d for 28 d)
Trial: 8759372
Drug: Casein supplement
RxNorm normalized name: caseins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Casein supplement
Trial: 2007444
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg of Prostaglandin E2 (PGE2) administered by intravaginal route in a hydroxyethyl cellulose gel medium
Trial: 31048444
Drug: Sodium bicarbonate
RxNorm normalized name: Sodium Bicarbonate
DrugBank: Sodium bicarbonate (DB01390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium bicarbonate solution (4.2 g in 50 mL of 50 mmol/L) with standard preoperative infusion of normal saline (1.5 L)